Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 24.58 USD 2.12% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Nurix Therapeutics Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nurix Therapeutics Inc
Additional Paid In Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Nurix Therapeutics Inc
NASDAQ:NRIX
Additional Paid In Capital
$746.3m
CAGR 3-Years
24%
CAGR 5-Years
230%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Additional Paid In Capital
$20.9B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Additional Paid In Capital
$7B
CAGR 3-Years
18%
CAGR 5-Years
21%
CAGR 10-Years
2%
Amgen Inc
NASDAQ:AMGN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Additional Paid In Capital
$7.1B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Additional Paid In Capital
$12.3B
CAGR 3-Years
19%
CAGR 5-Years
24%
CAGR 10-Years
18%

See Also

What is Nurix Therapeutics Inc's Additional Paid In Capital?
Additional Paid In Capital
746.3m USD

Based on the financial report for Nov 30, 2023, Nurix Therapeutics Inc's Additional Paid In Capital amounts to 746.3m USD.

What is Nurix Therapeutics Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
230%

Over the last year, the Additional Paid In Capital growth was 5%. The average annual Additional Paid In Capital growth rates for Nurix Therapeutics Inc have been 24% over the past three years , 230% over the past five years .

Back to Top